Postoperative atrial fibrillation and mortality: Do the risks merit changes in clinical practice?

Journal of the American College of Cardiology

Volumn 43, Issue 5, 2004, Pages 749-751

  Levy, Daniel ^a,b,c,d   Kannel, William B ^a,c  

^a Blood Inst's F   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANAMNESIS; ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE COURSE; EMBOLISM; EPIDEMIOLOGICAL DATA; HEART ATRIUM FIBRILLATION; HEART OUTPUT; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; NOTE; OUTCOMES RESEARCH; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SURGICAL MORTALITY; SURGICAL PATIENT;

EID: 1542271711     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.011     Document Type: Editorial

References (17)

1. American Heart Association2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2002.
2. Benjamin E.J., Levy D., Vaziri S.M., D'Agositno R.B., Belanger A.J., Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 271:1994;840-844.
3. Wolf P.A., Benjamin E.J., Belanger A.J., et al. Secular trends in the prevalence of atrial fibrillation; the Framingham Study. Am Heart J. 131:1996;790-795.
4. Morbidity and Mortality: 2000 Cart Book on Cardiovascular, Lung and Blood Diseases. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute. U.S Department of Health and Human Services, 2000.
5. Wattigney W.A., Mensah G.A., Croft J.B. Increased atrial fibrillation mortality United states, 1980-1998. Am J Epidemiol. 155:2002;819-826.
6. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231-66.
7. Braunwald E. Shattuck Lecture - cardiovascular medicine at the turn of the millennium Triumphs, concerns, and opportunities. N Engl J Med. 337:1997;1360-1369.
8. Gajewski J., Singer R.B. Mortality in an insured population with atrial fibrillation. JAMA. 245:1981;1540-1544.
9. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation The framingham study. N Engl J Med. 306:1982;1018-1022.
10. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on risk of death The framingham heart study. Circulation. 98:1998;946-952.
11. Creswell L.L., Schuessler R.B., Rosenbloom M., Cox J.L. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 56:1993;539-549.
12. Villareal R.P., Hariharan R., Liu B.C., et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 43:2004;742-748.
13. Shinbane J.S., Wood M.A., Jensen D.N., et al. Tachycardia-induced cardiomyopathy; a review of animal models and clinical studies. J Am Coll Cardiol. 29:1997;709-715.
14. Crijns H.J., van den Berg M.P., van Gelder I.C., et al. Management of atrial fibrillation in the setting of heart failure. Eur Heart J. 18:(Suppl C):1997;C45-C49.
15. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality The framingham heart study. Circulation. 107:2003;2920-2925.
16. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo The cardiac arrhythmia suppression trial. N Engl J Med. 324:1991;781-788.
17. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 347:2002;1825-1833.